Many vital drugs are getting harder to come by, including chemotherapy agent Fluorouracil (5-FU), due to national shortages. These shortages can be attributed to increased demand for a drug, manufacturing delays and other circumstances. When a chemotherapy drug is in short supply, patients who rely on this life-saving treatment cannot adhere to their treatment schedules. Often, patients aren’t even aware the drug they rely on is in short supply until they are turned away for treatment!
This a national healthcare crisis, but you can help.
The Preserving Access to Life-Saving Medications Act (H.R. 2245)/(S. 296) was introduced earlier this year. This legislation would require manufacturers to notify the FDA about manufacturing problems or when a drug is to be discontinued. The bill also requires that the FDA maintain an online list of drugs in shortage situations and revises the agency’s definition of “medically necessary.” The proposed bills will help the FDA prevent drug shortages and ensure that cancer patients’ treatment schedules are uninterrupted.
Take action now! We urge you to contact your legislators and ask for their support of H.R. 2245/S. 296. No cancer patient should have to deal with an unanticipated drug shortage while fighting the bravest battle of their life.
To see the full bills, visit the Thomas Legislative Information Website and search for S. 296 or H.R. 2245.
Your SenatorsYour Representative
Please Support the Preserving Access to Life-Saving Medications Act (H.R. 2245/S. 296)
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP]
©2013 Colon Cancer Alliance
Newly Diagnosed | Friends & Family | Programs & Events | Prevention
About Us | About Colon Cancer | Get Involved | Support Us | Shop CCA | News | Español | Contact Us | Home
1025 Vermont Ave., NW, Suite 1066, Washington, DC 20005